![Quiver Logo](/static/img/logo-icon.png)
![HUMAW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/humaw.png)
Humacyte, Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HUMAW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of HUMAW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HUMAW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to HUMAW
Recent picks made for HUMAW stock on CNBC
ETFs with the largest estimated holdings in HUMAW
Flights by private jets registered to HUMAW
![Quiver Logo](/static/img/logo-icon.png)